In our cohort, the presence of the A/A genotype has been shown to confer increased susceptibility for both anti-Ro/SSA positive SS and SS-related lymphoma, but not for their anti-Ro/SSA negative counterparts compared to healthy controls. This evidence concerns the gene TRIM21 and synovial sarcoma.